Asset Details
Do you wish to reserve the book?
Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis
Do you wish to request the book?
Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis
2025
Overview
Background
Incidence of oropharyngeal cancer (OPC) in the United States (US) has increased significantly due to human papillomavirus infections. This study characterized OPC incidence rates (IRs) by subgroups to identify high-risk populations for future screening efforts.
Methods
We conducted a comprehensive analysis comprising a systematic review and meta-analysis of studies published since 2000 reporting OPC IRs in the US, supplemented by a primary analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program. From each source, we extracted cases and person-years to calculate IRs per 100,000 person-years (PY). Data from 11 studies selected for meta-analysis were analyzed using random-effects models. We stratified analyses by sex, age, race/ethnicity, and HIV status, as available.
Results
The meta-analysis found an overall OPC IR of 8.2 per 100,000 PY. Men had four times the incidence of OPC than women (13.4 and 3.6 per 100,000 PY, respectively). People living with HIV (PLWH) had the highest IR (27.6 per 100,000 PY), particularly men LWH (35.2 per 100,000 PY, compared to 12.4 in women LWH). SEER data confirmed sex differences, with low incidence in men < 50 years and in women of all ages, and a peak IR among men 60–79 years (32.4 per 100,000 PY). Among men aged 60–79, IRs were higher among White, Black, and American Indian/Alaskan Native (25.7–39.6 per 100,000 PY) than Hispanic/Latino or Asian American/Pacific Islander men (8.8–16.7 per 100,000 PY).
Conclusions
Men aged 50–79 years and PLWH are at highest risk for OPC, with IRs comparable with or exceeding those of other HPV-associated cancers in the US. Any future screening efforts should prioritize these groups while excluding low-risk populations, such as women and individuals < 50 years.
Registration:
PROSPERO CRD42024588671.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Age
/ Aged
/ Bias
/ Biomedical and Life Sciences
/ Cancer
/ Female
/ Health Promotion and Disease Prevention
/ HIV
/ HIV Infections - complications
/ HIV Infections - epidemiology
/ Human immunodeficiency virus
/ Humans
/ Male
/ Oncology
/ Oropharyngeal Neoplasms - epidemiology
/ Oropharyngeal Neoplasms - virology
/ Papillomavirus Infections - complications
/ Papillomavirus Infections - epidemiology
